Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Cynthia Ten Eyck
Observed names:
C Ten Eyck,
C. Ten Eyck,
Cynthia J. Ten Eyck
Observed institutions:
Mayo Clinic,
Johns Hopkins University,
Bristol-Myers Squibb (United States),
Johns Hopkins Hospital,
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
OpenAlex ID:
A5019494436
Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
2005
·
Ruben A. Mesa
, David Loegering
, et al.
·
Blood
·
117
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors
2010
·
Joleen Hubbard
, Charles Erlichman
, et al.
·
Investigational New Drugs
·
37
Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2011
·
Xiaonan Hou
, Fei Huang
, et al.
·
Molecular Cancer Therapeutics
·
23
PDF
Drug efflux by breast cancer resistance protein (BCRP) is a mechanism of resistance to the insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.
2009
·
P Haluska
, JM Carboni
, et al.
·
Cancer Research
·
3
HER receptor signaling confers resistance to IGF-1R targeted therapy
2008
·
P. Haluska
, J. M. Carboni
, et al.
·
Journal of Clinical Oncology
·
1
Supplementary Figure 2A from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Supplementary Figure 2B from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Supplementary Figure 3 from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Supplementary Figure 1 from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
PDF
Supplementary Figure Legends from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Supplementary Figure 2B from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
PDF
Supplementary Figure 2A from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
PDF
Supplementary Figure 1 from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Supplementary Figure Legends from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
PDF
Data from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Data from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
Supplementary Figure 3 from Drug Efflux by Breast Cancer Resistance Protein Is a Mechanism of Resistance to the Benzimidazole Insulin-Like Growth Factor Receptor/Insulin Receptor Inhibitor, BMS-536924
2023
·
Xiaonan Hou
, Fei Huang
, et al.
PDF
P-01 HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924
2008
·
P. Haluska
, J.M. Carboni
, et al.
·
Growth Hormone & IGF Research
Show more works
View as search
Works count:
18
Citation count:
181
H-index:
3
I10-index:
3
Year
Topic
Type